N-of-One® Presents Data at AGBT 2014 Reporting Uncommon BRAF Mutations in Up to 50% of BRAF Positive Tumors

  • Posted by 3mediaweb
  • On February 24, 2014
  • 0 Comments
— New Findings on BRAF Gene Mutations in Melanoma and Other Cancers Provide Potential for Alternative Therapies — LEXINGTON, Mass., February 24, 2014 — N-of-One, the leading provider of molecular interpretation and therapeutic strategies for precision medicine for oncology, presented data suggesting that up to 50% of BRAF gene mutations can be found in locations […]
Read More

N-of-One® and Appistry Partner to Provide Comprehensive, Affordable Genomic Sequencing Analysis and Interpretation Solutions

  • Posted by 3mediaweb
  • On February 18, 2014
  • 0 Comments
— Partnership Addresses the Analysis and Interpretation Hurdles That Limit the Impact of Precision Medicine — ST. LOUIS, Mo. and LEXINGTON, Mass., February 18, 2014 — Appistry, a leading provider of high-performance computing and analytics solutions for next-generation medicine, and N-of-One, the leading provider of molecular interpretation and therapeutic strategies for personalized medicine in cancer […]
Read More
BACK TO
TOP
LEARN
MORE